FDA approves epinephrine nasal spray, a needle-free alternative to EpiPen

The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including anaphylaxis. 

The agency said it approved Neffy, from ARS Pharmaceuticals, for use in adult and pediatric patients who weigh at least 30 kilograms (about 66 pounds).  

In a surprise move last year, FDA declined to approve Neffy despite a favorable recommendation from an advisory committee.